Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of stock-based compensation

v3.22.2.2
Stockholders' Equity (Details) - Schedule of stock-based compensation - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Schedule of stock-based compensation [Abstract]        
Research and development $ 17,601 $ 119,627 $ 46,409 $ 176,730
General and administrative 417,355 837,931 844,970 1,101,272
Total $ 434,956 $ 957,558 $ 891,379 $ 1,278,002